secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medline Inc. (MDLN)
CIK:        0002046386
Form:       8-K
Filed at:   2025-12-22T23:59:59+00:00
Accession:  0001193125-25-328884
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.03, 5.03, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medline completes IPO of ~248M shares at $29; uses proceeds to repay debt and buy out pre-IPO owners
--------------------------------------------------------------------------------

- IPO closed Dec 18, 2025: 248,439,654 shares of Class A common stock at $29.00 per share.
- Net proceeds from 179M shares ($5,078M) used to purchase Common Units; Medline Holdings repaid $731M under New Euro Term Loan and $3,292M under 2028 Refinancing Term Loan.
- Proceeds from 37M shares ($1,051M) and 32.4M shares ($919M) from over-allotment used to purchase/redeem shares and Common Units from certain pre-IPO owners.
- Todd M. Bluedorn appointed to Board and Audit Committee; granted RSUs with $300,000 grant date fair value vesting March 30, 2027.
- Amended and restated certificate of incorporation and bylaws effective; authorized capital stock includes 50B shares Class A, 50B shares Class B, and 5B shares preferred.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2046386/000119312525328884/0001193125-25-328884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2046386/000119312525328884/d933672d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-328884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer